Individualized Connectivity-Guided Versus Conventional Targeting of Accelerated Theta-Burst Stimulation in Depression: A Randomized, Double-Blind, Parallel-Design Trial [0.03%]
基于个体化连接指导的与常规靶点的加速θ爆发刺激治疗抑郁的随机双盲平行分组试验：一项概念验证性研究
Mingzhu Li,Zijia Wu,Xuefeng Lu et al.
Mingzhu Li et al.
Objective: Scalp-based repetitive transcranial magnetic stimulation targeting the left dorsolateral prefrontal cortex (DLPFC) does not account for interindividual variability. This trial was designed to determine whether ...
Pediatric Gender Medicine: Psychiatry's Duty to Model Respectful Disagreement [0.03%]
儿科性别医学：精神病学践行尊重性分歧的使命
Kathleen McDeavitt,Kristopher Kaliebe
Kathleen McDeavitt
Psychiatry's Duty to Model Respectful Disagreement: Response to McDeavitt and Kaliebe [0.03%]
精神病学必须践行尊重性分歧的义务：回应McDeavitt和Kaliebe博士
Aaron S Breslow,Arjee Restar,Elizabeth Cavic et al.
Aaron S Breslow et al.
Brian A Coffman,Alfredo Sklar,Fran Lopez Caballero
Brian A Coffman
Subtypes of Somatostatin and Other Interneurons Are Real, Whether We Believe in Them or Not [0.03%]
是否存在梭状细胞等亚型神经元与你是否相信无关
Laramie Duncan
Laramie Duncan
Schizophrenia Beyond Genome-Wide Association Studies: It's About Time [0.03%]
超越全基因组关联研究的精神分裂症研究：是时候这样做了
Giulio Pergola,Daniel R Weinberger
Giulio Pergola
The discovery of potentially many hundreds of risk genes for schizophrenia does not resolve the mystery of the illness at the level of an individual. The diversity of implicated gene functions has encouraged speculation that there are conve...
Copy Number Variation in Schizophrenia: Developmental Timing and Clinical Heterogeneity [0.03%]
精神分裂症中的拷贝数变异：发育时期和临床异质性
Rebecca Birnbaum
Rebecca Birnbaum
Determinants of Nonspecific Response to Treatment in Randomized Controlled Trials of Major Depressive Disorder: A Narrative Review [0.03%]
随机对照试验中重度抑郁症非特异性反应的决定因素：叙述性综述
Clotilde Guidetti,Riccardo De Giorgi,Nathan T M Huneke et al.
Clotilde Guidetti et al.
The design, conduct, and interpretation of double-blind randomized placebo-controlled clinical trials in major depressive disorder (MDD) are complicated by determinants of nonspecific response to treatment (NSRT). This narrative review prov...
Joseph P Schacht,Joseph T Sakai,Kristen Raymond et al.
Joseph P Schacht et al.
Objective: Accumulating preclinical and observational evidence suggests that glucagon-like peptide-1 receptor agonists, including semaglutide, reduce alcohol consumption. This phase 2 double-blind, randomized, parallel-ar...